Title of article
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
Author/Authors
Giuseppe Remuzzi، نويسنده , , Mariadomenica Lesti، نويسنده , , Eliana Gotti، نويسنده , , Maria Ganeva، نويسنده , , Borislav D. Dimitrov، نويسنده , , Bogdan Ene-Iordache، نويسنده , , Giulia Gherardi، نويسنده , , Donato Donati، نويسنده , , Maurizio Salvadori، نويسنده , , Silvio Sandrini، نويسنده , , Umberto Valente، نويسنده , , Giuseppe Segoloni، نويسنده , , Georges Mourad، نويسنده , , Stefano Federico، نويسنده , , Paolo R، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
10
From page
503
To page
512
Abstract
Background
Mycophenolate mofetil has replaced azathioprine in immunosuppression regimens worldwide to prevent graft rejection. However, evidence that its antirejection activity is better than that of azathioprine has been provided only by registration tri
Journal title
The Lancet
Serial Year
2004
Journal title
The Lancet
Record number
586803
Link To Document